ORGANIC
LETTERS
2009
Vol. 11, No. 24
5638-5641
An Aldol Approach to the Total
Synthesis of Pamamycin 621 A
Guo-Bao Ren and Yikang Wu*
State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai
Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road,
Shanghai 200032, China
Received October 3, 2009
ABSTRACT
Pamamycin 621A was synthesized through a convergent route, with the THF rings constructed from Evans aldols in the presence of the chiral
auxiliaries without suffering racemization or elimination. The basic amino group was introduced at a late stage through reduction of an azido
group with n-Bu3SnH, which also demonstrates for the first time the great potential of this largely forgotten reduction protocol in synthesis
of multifunctional substrates.
Pamamycin 621A (1) is one of the 19 macrodiolide homo-
logues generated by various Streptomyces species.1 Because
of their interesting structures and bioactivities (such as
autoregulatory, anionophoric, antifungal, antibacterial activ-
ity), pamamycins have received remarkable attention from
the synthetic community since the late 1990s and conse-
quently promoted the appearance of many elegant syntheses.2
However, most studies were directed toward 607, the
simplest member in the family. Among the remainder, only
621A and 635B (Figure 1) have been synthesized to date.2g
syn-aldols generated by Evans/Crimmins aldolization4 with-
out suffering from the otherwise readily occurring side
(2) For total syntheses, see: (a) Germay, O.; Kumar, N.; Thomas, E. J.
Tetrahedron Lett. 2001, 42, 4969–4974. (b) Lee, E.; Jeong, E. J.; Kang,
E. J.; Sung, L. T.; Hong, S. K. J. Am. Chem. Soc. 2001, 123, 10131–10132.
(c) Jeong, E. J.; Kang, E. J.; Sung, L. T.; Hong, S. K.; Lee, E. J. Am.
Chem. Soc. 2002, 124, 14655–14662. (d) Wang, Y.; Bernsmann, H.; Gruner,
M.; Metz, P. Tetrahedron Lett. 2001, 42, 7801–7804. (e) Kang, S. H.; Jeong,
J. W.; Hwang, Y. S.; Lee, S. B. Angew. Chem., Int. Ed. 2002, 41, 1392–
1395. (f) Lanners, S.; Norouzi-Arasi, H.; Salom-Roig, X. J.; Hanquet, G.
Angew. Chem., Int. Ed. 2007, 46, 7086–7089. (g) Fischer, P.; Segovia,
A. B. G.; Gruner, M.; Metz, P. Angew. Chem., Int. Ed. 2005, 44, 6231–
6234. For fragment syntheses, see: (h) Walkup, R. D.; Park, G. Tetrahedron
Lett. 1988, 29, 5505–5508. (i) Walkup, R. D.; Kim, S. W.; Wagy, S. D. J.
Org. Chem. 1993, 58, 6486–6490. (j) Walkup, R. D.; Kim, S. W. J. Org.
Chem. 1994, 59, 3433–3441. (k) Walkup, R. D.; Kim, Y. S. Tetrahedron
Lett. 1995, 36, 3091–3094. (l) Mavropoulos, I.; Perlmutter, P. Tetrahedron
Lett. 1996, 37, 3751–3754. (m) Arista, L.; Gruttadauria, M.; Thomas, E. J.
Synlett 1997, 627–628. (n) Mandville, G.; Girard, C.; Bloch, R. Tetrahedron:
Asymmetry 1997, 8, 3665–3673. (o) Mandville, G.; Bloch, R. Eur. J. Org.
Chem. 1999, 2303–2307. (p) Solladie, G.; Salom-Roig, X. J.; Hanquet, G.
Tetrahedron Lett. 2000, 41, 551–554. (q) Bernsmann, H.; Hungerhoff, B.;
Fechner, R.; Frohlich, R.; Metz, P. Tetrahedron Lett. 2000, 41, 1721–1724.
(r) Calter, M. A.; Bi, F. C. Org. Lett. 2000, 2, 1529–1531. (s) Solladie, G.;
Salom-Roig, X. J.; Hanquet, G. Tetrahedron Lett. 2000, 41, 2737–2740.
(t) Bernsmann, H.; Frohlich, R.; Metz, P. Tetrahedron Lett. 2000, 41, 4347–
4351. (u) Bernsmann, H.; Gruner, M.; Metz, P. Tetrahedron Lett. 2000,
41, 7629–7633. (v) Bernsmann, H.; Gruner, M.; Frolich, R.; Metz, P.
Tetrahedron Lett. 2001, 42, 5377–5380. (w) Miura, A.; Takigawa, S.-y.;
Furuya, Y.; Yokoo, Y.; Kuwahara, S.; Kiyota, H. Eur. J. Org. Chem. 2008,
4955–4962.
A prominent structural feature present in all pamamycins
is the occurrence of three 2,5-cis-disubstituted-THF rings
incorporated into the “hidden” polyketide chains. Recently,
en route to a total synthesis of nonactin (4) we developed
an effective means3 for construction of similar rings from
(1) (a) McCann, P. A.; Pogell, B. M. J. Antibiot. 1979, 32, 673–678.
(b) Kondo, S.; Yasui, K.; Natsume, M.; Katayama, M.; Marumo, S. J.
Antibiot. 1988, 41, 1196–1204. (c) Natsume, M.; Kondo, S.; Marumo, S.
J. Chem. Soc., Chem. Commun. 1989, 1911–1913. (d) Natsume, M.; Yasui,
K.; Kondo, S.; Marumo, S. Tetrahedron Lett. 1991, 32, 3087–3090. (e)
Natsume, M.; Tazawa, J.; Yagi, K.; Abe, H.; Kondo, S.; Marumo, S. J.
Antibiot. 1995, 48, 1159–1164. (f) Natsume, M.; Honda, A.; Oshima, Y.;
Abe, H.; Kondo, S.; Tanaka, F.; Marumo, S. Biosci. Biotechnol. Biochem.
1995, 59, 1766–1768. For a recent review, see: (g) Metz, P. Top. Curr.
Chem. 2005, 244, 215–249.
10.1021/ol902290v 2009 American Chemical Society
Published on Web 11/19/2009